According to a new report from Intel Market Research, the global Whole House Surge Protection Device market was valued at USD 1,149 million in 2024 and is projected to reach USD 1,799 million by 2032, growing at a CAGR of 6.7% during the forecast period (2025–2032). This growth is propelled by increasing electrical safety awareness, rising smart home adoption, and stricter building codes mandating surge protection installations.
Read MoreAccording to a new report from Intel Market Research, the global KNX Home Automation market was valued at US$ 7,568.40 Million in 2023 and is projected to reach US$ 16,579.87 Million by 2030, growing at a robust CAGR of 11.61% during the forecast period (2024–2030). This significant growth is driven by increasing consumer demand for smart homes, a strong focus on energy efficiency and sustainability, and the expanding integration of IoT devices in residential and commercial buildings.
Read MoreAccording to a new report from Intel Market Research, the global Salt Chlorine Generator for Swimming Pool market was valued at USD 318 million in 2024 and is projected to reach USD 482 million by 2032, growing at a CAGR of 6.3% during the forecast period (2025–2032). This growth is driven by increasing demand for automated pool sanitation solutions and rising global swimming pool installations across residential and commercial sectors.
Read MoreAccording to a new report from Intel Market Research, the global Salt Chlorine Generator for Swimming Pool market was valued at USD 318 million in 2024 and is projected to reach USD 482 million by 2032, growing at a CAGR of 6.3% during the forecast period (2025–2032). This growth is driven by increasing demand for automated pool sanitation solutions and rising global swimming pool installations across residential and commercial sectors.
Read MoreAccording to a new report from Intel Market Research, the global robotic liquid handling equipment market was valued at USD 1,155 million in 2024 and is projected to reach USD 1,774 million by 2032, growing at a robust CAGR of 6.5% during the forecast period (2025–2032). This substantial growth trajectory is primarily being driven by rising investments in biopharmaceutical R&D, expanding genomics and proteomics research applications, and the critical need for laboratory efficiency gains across pharmaceutical, biotechnology, and clinical diagnostics sectors worldwide.
Read More